← Leaderboards
John P Bantle
University Of Minnesota Twin Cities
$635,626
Attributed
$635,626
Total exposure
16
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $149.9K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$635,626 · 16
By mechanism
M01$635,626 · 16
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Kalpna Gupta$21,163,908
- Gregory M Vercellotti$16,001,591
- William R Kennedy$6,783,741
- Dorothy K Hatsukami$58,862,572
- Seong-Gi Kim$16,023,782
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman Therapy EvaluationDiabetes Mellitus TherapyEpidemiologyBody WeightClinical TrialsFundingInstitutionCarbohydrate BalanceGrantParticipantInsulin Dependent Diabetes MellitusDiabetes MellitusSourceComputer Retrieval Of Information On Scientific Projects DatabaseResearch PersonnelNoninsulin Dependent Diabetes MellitusResourcesUnited States National Institutes Of HealthMedical ComplicationBlood PressureDiabetic RetinopathyBlood Lipid
Grant awards (23)
BARI 2D: BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES$27,077
M01 · FY2009 · RR · contact PI
EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS TRIAL (EDIC)$21,222
M01 · FY2009 · RR · contact PI
BARI 2D: BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES$61,397
M01 · FY2008 · RR · contact PI
EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS TRIAL (EDIC)$30,037
M01 · FY2008 · RR · contact PI
BARI 2D: BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES$53,865
M01 · FY2007 · RR · contact PI
EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS TRIAL (EDIC)$25,062
M01 · FY2007 · RR · contact PI
BARI 2D: BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES$64,920
M01 · FY2006 · RR · contact PI
METABOLIC EFFECTS OF ALCOHOL IN THE FORM OF WINE IN PERSONS WITH TYPE 2 DIABETES$59,182
M01 · FY2006 · RR · contact PI
EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS TRIAL (EDIC)$25,825
M01 · FY2006 · RR · contact PI
BARI 2D: BYPASS ANGIOPLASTY REVASCULARIZATION INVESTIGATION 2 DIABETES$73,401
M01 · FY2005 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTIONS AND COMPLICATIONS TRIAL (EDIC)$34,591
M01 · FY2005 · RR
BARI 2D: Bypass Angioplasty Revascularization Investigation 2 Diabetes$63,211
M01 · FY2004 · RR
Epidemiology of Diabetes Interventions and Complications Trial (EDIC)$39,553
M01 · FY2004 · RR
Combination Weight Loss Therapy for Type 2 Diabetes Mellitus$11,459
M01 · FY2004 · RR
EPIDEMIOLOGY OF DIABETES, INTERVENTIONS AND COMPLICATIONS TRIAL (EDIC)$0
M01 · FY2002 · RR
PHARMACOLOGIC INDUCTION OF WEIGHT LOSS TO TREAT TYPE II DIABETES MELLITUS$0
M01 · FY2002 · RR
PHARMACOLOGIC INDUCTION OF WEIGHT LOSS TO TREAT TYPE II DIABETES MELLITUS$0
M01 · FY2002 · RR
EPIDEMIOLOGY OF DIABETES, INTERVENTIONS AND COMPLICATIONS TRIAL (EDIC)$0
M01 · FY2002 · RR
EPIDEMIOLOGY OF DIABETES, INTERVENTIONS AND COMPLICATIONS TRIAL (EDIC)$0
M01 · FY2001 · RR
PHARMACOLOGIC INDUCTION OF WEIGHT LOSS TO TREAT TYPE II DIABETES MELLITUS$0
M01 · FY2001 · RR
GLUCOSE MONITORING WITH THE LIFEGUARD DERMAL ISF SYSTEM$44,824
M01 · FY2000 · RR
PHARMACOLOGIC INDUCTION OF WEIGHT LOSS TO TREAT TYPE II DIABETES MELLITUS$0
M01 · FY2000 · RR
EPIDEMIOLOGY OF DIABETES, INTERVENTIONS AND COMPLICATIONS TRIAL (EDIC)$0
M01 · FY2000 · RR